AG
PFE icon

AIA Group’s Pfizer PFE Stock Holding History

AIA Group’s Portfolio PFE Stock Details PFE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$15.4M Sell
638,590
-194,773
-23% -$5.09M 0.19% 71
2026
Q1 		$23.4M Buy
833,363
+106,683
+15% +$2.84M 0.34% 48
2025
Q4 		$18.1M Buy
726,680
+243,432
+50% +$6.14M 0.27% 51
2025
Q3 		$12.3M Buy
483,248
+279,705
+137% +$6.9M 0.22% 73
2025
Q2 		$4.93M Sell
203,543
-44,795
-18% -$1.04M 0.11% 106
2025
Q1 		$6.29M Buy
248,338
+56,334
+29% +$1.47M 0.15% 73
2024
Q4 		$5.09M Sell
192,004
-62,937
-25% -$1.71M 0.12% 80
2024
Q3 		$7.38M Sell
254,941
-15,410
-6% -$450K 0.19% 61
2024
Q2 		$7.56M Buy
270,351
+91,704
+51% +$2.52M 0.22% 54
2024
Q1 		$4.96M Buy
178,647
+99,451
+126% +$2.76M 0.16% 65
2023
Q4 		$2.28M Sell
79,196
-8,842
-10% -$267K 0.09% 115
2023
Q3 		$2.92M Buy
88,038
+34,623
+65% +$1.22M 0.14% 79
2023
Q2 		$1.96M Sell
53,415
-80,044
-60% -$3.12M 0.09% 103
2023
Q1 		$5.45M Sell
133,459
-31,162
-19% -$1.35M 0.3% 35
2022
Q4 		$8.44M Buy
164,621
+47,342
+40% +$2.27M 0.51% 26
2022
Q3 		$5.13M Sell
117,279
-80,803
-41% -$3.93M 0.34% 34
2022
Q2 		$10.4M Buy
198,082
+106,646
+117% +$5.43M 0.56% 27
2022
Q1 		$4.73M Buy
91,436
+28,594
+46% +$1.48M 0.21% 46
2021
Q4 		$3.71M Buy
62,842
+42,660
+211% +$2.11M 0.18% 69
2021
Q3 		$868K Buy
20,182
+3,040
+18% +$135K 0.05% 148
2021
Q2 		$688K Sell
17,142
-38,983
-69% -$1.52M 0.05% 136
2021
Q1 		$2.03M Sell
56,125
-6,440
-10% -$229K 0.29% 65
2020
Q4 		$2.18M Buy
+62,565
New +$2.29M 0.25% 56

Other funds holding PFE

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

AIA Group's PFE Position: Q2 2026 in Review

AIA Group reduced its Pfizer (PFE) stake by 23% in Q2 2026, selling an estimated $5.09M and leaving 638,590 shares worth $15.4M. The position accounts for 0.19% of the portfolio, ranked #71.

AIA Group first reported a position in PFE in Q4 2020 and has held it in 23 quarters since. The position peaked at $23.4M in Q1 2026. 2,818 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

  • AIA Group held 638,590 shares of Pfizer worth $15.4M as of Q2 2026.
  • AIA Group sold 194,773 Pfizer shares in Q2 2026, an estimated $5.09M.
  • Pfizer made up 0.19% of AIA Group's portfolio in Q2 2026, its #71 holding.
  • AIA Group first reported a position in Pfizer in Q4 2020 and has held it in 23 quarters since.
  • AIA Group's Pfizer position peaked at $23.4M in Q1 2026.
  • 2,818 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on AIA Group's 13F filing for Q2 2026, filed 31 Jul 2026.